Made of Genes, a CataloniaBio & HealthTech member, has closed a €3-million pre Series-A capital increase led by Catalan family office FCV Equity. Other participants included the Scale Lab fund from the Crèdit Andorrà financial group and Break Off Capital (United Kingdom), as well as previous investors in the company like CG Health Ventures and business angel Albert Armengol (CEO of Doctoralia).

The capital raised will go to scale up the personalised health services Made of Genes offers, improve arrival to market and create new specialised products.

Recently, this company based in Esplugues de Llobregat (Barcelona) added a new test called Reactívate to its catalogue of services. This test shows whether a person has already had Covid-19, whether they are immunised, their probability of experiencing significant respiratory complications if infected and how to reduce the risk. It combines an analysis of genetic markers, IgG antibodies and biochemistry.

Photo: Óscar Flores, CEO of Made of Genes, and Miquel Bru, vice-president for Business Development - © Made of Genes